Matthew Stanton, CHIEF SCIENTIFIC OFFICER at Generation Bio Co. (GBIO), sold 29,131 shares at $28.02 ($806K) on 2021-01-11, disclosed to the SEC on 2021-01-13.
Open-market sale of $806k GBIO by CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.18 | 6,269 | $170K | 21.1% |
| 2 | $27.18 | 6,269 | $170K | 21.1% |
| 3 | $28.02 | 8,042 | $225K | 28.0% |
| 4 | $28.02 | 8,042 | $225K | 28.0% |
| 5 | $28.77 | 509 | $15K | 1.8% |
| Total | $27.67 avg | 29,131 |
| $806K |
| 100% |
| Filing → |
| GBIO | SELL | 2021-08-25 | $38K | — | Filing → |
| GBIO | SELL | 2021-08-11 | $34K | — | Filing → |
| GBIO | SELL | 2021-07-14 | $75K | — | Filing → |